Search

Your search keyword '"Ippazio Cosimo Antonazzo"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Ippazio Cosimo Antonazzo" Remove constraint Author: "Ippazio Cosimo Antonazzo" Topic medicine Remove constraint Topic: medicine
43 results on '"Ippazio Cosimo Antonazzo"'

Search Results

1. Immunogenicity of Recombinant Zoster Vaccine: A Systematic Review, Meta-Analysis, and Meta-Regression

2. Cost-effectiveness and budget impact analysis of siponimod in the treatment of secondary progressive multiple sclerosis in Italy

3. Statins Use in Patients with Cardiovascular Diseases and COVID-19 Outcomes: An Italian Population-Based Cohort Study

4. Real-World Clinical Outcomes and Replacement Factor VIII Consumption in Patients with Haemophilia A in Italy: A Comparison between Prophylaxis Pre and Post Octocog Alfa (BAY 81-8973)

5. Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis

6. Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres.

7. Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders.

8. Response to BNT162b2 mRNA COVID-19 vaccine among healthcare workers in Italy: a 3-month follow-up

9. Costs and effects of cardiovascular risk reclassification using the ankle-brachial index (ABI) in addition to the Framingham risk scoring in women

10. Adverse events with sacubitril/valsartan in the real world: Emerging signals to target preventive strategies from the FDA adverse event reporting system

11. Impact of COVID-19 Lockdown, during the Two Waves, on Drug Use and Emergency Department Access in People with Epilepsy: An Interrupted Time-Series Analysis

12. Global, regional, and national burden of stroke and its risk factors, 1990–2019 : a systematic analysis for the Global Burden of Disease Study 2019

13. Use of antidepressants during COVID19 outbreak: a real-world drug-utilization study

14. Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research

15. Myopathy with DPP-4 inhibitors and statins in the real world: investigating the likelihood of drug–drug interactions through the FDA adverse event reporting system

16. Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System

17. Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems

18. Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months

19. Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region

20. COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases

21. Antibiotic Use and Risk of Multiple Sclerosis: A Nested Case-Control Study in Emilia-Romagna Region, Italy

22. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study

23. Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

24. Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System

25. Post-stroke epilepsy and mortality: an observational study on healthcare administrative database

26. 5PSQ-101 Drug–drug interactions and potentially related adverse clinical events in patients with cardiovascular diseases

27. Patterns and trends of idarucizumab use in an Italian region: a probabilistic record-linkage approach in a real-life setting

28. PCSK9 Inhibitors' New Users: Analysis of Prescription Patterns and Patients' Characteristics from an Italian Real-world Study

29. Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting System

30. Drug-induced systemic lupus erythematosus: should immune checkpoint inhibitors be added to the evolving list?

31. Evolving Roles of Spontaneous Reporting Systems to Assess and Monitor Drug Safety

32. Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study

33. Drug-induced Kounis syndrome: A matter of pharmacovigilance

34. Long-acting injectable antipsychotics: Six-month follow-up of new outpatient treatments in Bologna Community Mental Health Centres

35. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis

36. Diabetes is associated with decreased migraine risk: A nationwide cohort study

37. Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping

38. The Burden of Chronic Heart Failure in Primary Care in Italy

39. PMH34 LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS

40. Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System

41. Raphanus sativus cv. Sango Sprout Juice Decreases Diet-Induced Obesity in Sprague Dawley Rats and Ameliorates Related Disorders

42. Hospitalisations by Drug interactions with nsaids in elderly poly-treated patients: outcome research on administrative databases

Catalog

Books, media, physical & digital resources